Citation:De Ruysscher D, Pijls-Johannesma M, Bentzen SM, Minken A, Wanders R, Lutgens L, et al 2006

Citation

De Ruysscher D, Pijls-Johannesma M, Bentzen SM, Minken A, Wanders R, Lutgens L, et al. Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer. J Clin Oncol 2006 Mar 1;24(7):1057-63 Available from: http://www.ncbi.nlm.nih.gov/pubmed/16505424.

Critical appraisals

• Assign a critical appraisal

Critical appraisal link	Clinical question	Assigned to	Status
De Ruysscher D, Pijls-Johannesma M, Bentzen SM, Minken A, Wanders R, Lutgens L, et al 2006	What is the optimal concurrent chemotherapy to be used for the treatment of limited stage small cell lung cancer with radiotherapy?	Associate Professor Michael Michael MBBS(Hons), BSc(Hons), MD, FRACP	completed
De Ruysscher D, Pijls-Johannesma M, Bentzen SM, Minken A, Wanders R, Lutgens L, et al 2006 2	What is the optimal timing of thoracic radiotherapy in patients receiving chemotherapy for limited stage SCLC?	Dr Jeremy Ruben MBBCh (Hons), FCRadOnc (SA), FRANZCR, Mmed, MD (Monash)	completed
De Ruysscher D, Pijls-Johannesma M, Bentzen SM, Minken A, Wanders R, Lutgens L, et al 2006 3	What is the optimal dose and fractionation schedule of thoracic radiotherapy in patients with limited stage SCLC?	Dr Jeremy Ruben MBBCh (Hons), FCRadOnc (SA), FRANZCR, Mmed, MD (Monash)	completed

Compare quality appraisals for each clinical question

• [[Clinical question:What is the optimal concurrent chemotherapy to be used for the treatment of limited stage small cell lung cancer with radiotherapy?|]] (compare critical appraisals)
• [[Clinical question:What is the optimal timing of thoracic radiotherapy in patients receiving chemotherapy for limited stage SCLC?|]] (compare critical appraisals)
• [[Clinical question:What is the optimal dose and fractionation schedule of thoracic radiotherapy in patients with limited stage SCLC?|]] (compare critical appraisals)

Cited by

1. Lung cancer review page
2. What is the optimal concurrent chemotherapy to be used for the treatment of limited stage small cell lung cancer with radiotherapy?
3. What is the optimal dose and fractionation schedule of thoracic radiotherapy in patients with limited stage SCLC?
4. What is the optimal timing of thoracic radiotherapy in patients receiving chemotherapy for limited stage SCLC?